Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Miles Andrews

Group Leader

MONASH UNIVERSITY

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Articles (8)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Kate Pilkington

Head of Cytometry

Malaghan Institute of Medical Research

NEW ZEALAND

View details

David Carbone

Ohio State University Medical Center

UNITED STATES

View details

Nigel Gordon Maher

Melanoma Institute Australia

AUSTRALIA

View details

Elizabeth Burton

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Michael White

Assistant Professor

UNITED STATES

View details

Manoj Chelvanambi

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

David R. Gandara

Co-Director, Center for Experimental Therapeutics in Cancer

University of California Davis Comprehensive Cancer Center

UNITED STATES

View details

Mark Shackleton

Professor Director of Oncology

Alfred Health

AUSTRALIA

View details

Neeraj Agarwal

Faculty Member

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miles Andrews

Research Interests

Explore related searches

Articles (8)

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation

Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Design, optimisation and standardisation of a high‐dimensional spectral flow cytometry workflow assessing T‐cell immunophenotype in patients with melanoma

UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.

Collaborators (9)

Kate Pilkington

David Carbone

Nigel Gordon Maher

Elizabeth Burton

Michael White

Manoj Chelvanambi

David R. Gandara

Mark Shackleton

Neeraj Agarwal

Make your next move.